Delivery Order SPE2DB20D9329-SPE2DB23FZJ83
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $18,526.83 firm fixed-price contract is for the supply of Trikafta, a prescription medication used to treat cystic fibrosis. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This single-award...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $74,107.32 firm fixed-price contract is for the delivery of Trikafta, a prescription drug used to treat cystic fibrosis. The award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler located in Park Ridge, Illinois. The order, valued at $18,526.83, is for the delivery of Trikafta 100-50-75 mg/75 mg packets, a medication used to treat cystic fibrosis. The award is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, which runs...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) on June 17, 2024 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $18,526.83 firm fixed-price contract provides the DLA with Trikafta, a prescription medication used to treat cystic fibrosis. This order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group that allows the DLA to issue delivery orders for a...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $36,637.50 contract is for the delivery of the specialized pharmaceutical product Trikafta, a medication used to treat cystic fibrosis. The delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $17,702.98 contract is for the supply of Trikafta, a medication used to treat cystic fibrosis. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This single-award IDC allows the DLA to...
- This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $18,488.12, is a delivery order for the pharmaceutical product Trikafta, a cystic fibrosis medication. The award is part of a larger Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at $499,999,999 and valid through November 2026. This IDC allows the DLA to issue firm...
- This federal contract was awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The firm fixed-price delivery order, valued at $55,580.49, is for the supply of Trikafta, a specialty pharmaceutical product used to treat cystic fibrosis. The contract is part of a larger indefinite delivery contract (IDC) with a ceiling value of up to $499,999,999 that...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $18,488.12, is for the delivery of Trikafta, a specialized medication, to support the medical supply needs of military healthcare facilities. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $37,053.68, is for the delivery of Trikafta 100-50-75 mg/150 mg oral pharmaceutical medication. The contract is a firm fixed-price delivery order placed under a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group that has a ceiling value of up to...
- SPE2DB20D9329Indefinite Delivery Contract
- SPE2DB20D9329-SPE2DB23FZJ83Delivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $18,318.75 firm fixed-price contract is for the delivery of Trikafta, a medication used to treat cystic fibrosis. The award is issued under a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA, which allows the agency to issue delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military healthcare facilities worldwide. This IDC contract, designated SPE2DB, does not have a set-aside requirement. Through this vehicle and other prime vendor contracts, DMS Pharmaceutical Group provides both routine and critical medications to the Department of Defense, solidifying its position as a key supplier in the federal pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.3k | 2/2/23 |